Dr. Reddy's Laboratories Limited American Depositary Shares (RDY) Stock Price

RDYStock

$12.34+29.85%52W

Market Cap$10.28B

P/E23.98x

PEG Ratio1.62

Div yield0.71%

Beta0.19

RDY Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-17.25%

Price vs S&P 500 (4W)1.37%

PEG Ratio1.62

VGM Score42.31

P/E Ratio (Annual)23.98x

Indicated Dividend Yield (Annual)0.71%

P/CF (Annual)17.73x

Book Value / Share (Quarterly)$4.77

P/TBV (Annual)3.82x

Indicated Dividend (Annual)$0.08

Revenue Growth (3Y)10.96%

Cash Flow / Share (Quarterly)$0.23

Payout Ratio (TTM)49.43%

Price vs S&P 500 (YTD)-18.00%

Gross Margin (TTM)61.43%

Net Profit Margin (TTM)9.70%

EPS (TTM)$0.41

10-Day Avg Trading Volume1.65M

EPS Excl Extra (TTM)$0.41

Revenue Growth (5Y)12.09%

EPS (Annual)$0.53

Dividend / Share (Annual)$0.08

ROI (Annual)9.20%

Gross Margin (Annual)61.32%

Net Profit Margin (5Y Avg)15.62%

Cash / Share (Quarterly)$1.18

P/E Basic Excl Extra (TTM)31.22x

Revenue Growth QoQ (YoY)-5.51%

EPS Growth (5Y)-15.60%

P/E Normalized (Annual)23.98x

ROA (Last FY)7.22%

Revenue Growth TTM (YoY)-0.87%

EBITD / Share (TTM)$0.30

ROE (5Y Avg)15.68%

Operating Margin (TTM)9.09%

Cash Flow / Share (Annual)$0.23

P/B Ratio2.66x

P/B Ratio (Quarterly)2.76x

Net Income / Employee (Annual)$16,319

EV / Revenue (TTM)6.52x

Net Interest Coverage (TTM)13.50x

ROA (TTM)2.79%

EPS Growth QoQ (YoY)-68.68%

EV / EBITDA (TTM)44.65x

EPS Incl Extra (Annual)$0.53

Current Ratio (Annual)1.80x

Quick Ratio (Quarterly)1.34x

3-Month Avg Trading Volume2.42M

52-Week Price Return29.85%

EV / Free Cash Flow (Annual)58.26x

P/E Incl Extra (TTM)31.22x

Revenue / Employee (TTM)$129,231

Tangible BV / Share (Quarterly)$3.45

P/S Ratio (Annual)2.99x

Asset Turnover (Annual)0.58x

52-Week High$14.83

Operating Margin (5Y Avg)18.06%

EPS Excl Extra (Annual)$0.53

CapEx CAGR (5Y)25.05%

Tangible BV CAGR (5Y)14.17%

26-Week Price Return-6.00%

Quick Ratio (Annual)1.30x

13-Week Price Return-10.47%

Total Debt / Equity (Annual)0.20x

Current Ratio (Quarterly)1.80x

Enterprise Value$11.19B

Revenue / Share Growth (5Y)-18.83%

Asset Turnover (TTM)0.29x

Book Value / Share Growth (5Y)-15.60%

Revenue / Employee (Annual)$131,068

Inventory Turnover (Annual)1.64x

Pretax Margin (Annual)16.00%

Cash / Share (Annual)$1.12

3-Month Return Std Dev22.74%

Gross Margin (5Y Avg)65.12%

Net Income / Employee (TTM)$12,532

EBITDA CAGR (5Y)10.75%

EBITDA Interim CAGR (5Y)-18.34%

ROE (Last FY)11.07%

Net Interest Coverage (Annual)11.04x

EPS Basic Excl Extra (Annual)$0.53

P/FCF (TTM)54.88x

Receivables Turnover (TTM)3.52x

EV / Free Cash Flow (TTM)58.26x

Total Debt / Equity (Quarterly)0.20x

EPS Incl Extra (TTM)$0.41

Receivables Turnover (Annual)3.52x

ROI (TTM)3.58%

Dividend Growth Rate (5Y)-20.37%

P/S Ratio (TTM)3.03x

Pretax Margin (5Y Avg)20.79%

Revenue / Share (Annual)$4.24

Tangible BV / Share (Annual)$3.45

Forward P/E24.38x

Free OCF CAGR (5Y)-4.55%

Price vs S&P 500 (52W)20.79%

P/E Ratio (TTM)31.22x

EPS Growth TTM (YoY)-43.24%

Year-to-Date Return-6.25%

5-Day Price Return2.01%

EPS Normalized (Annual)$0.53

ROA (5Y Avg)10.86%

Net Profit Margin (Annual)12.45%

Month-to-Date Return4.19%

Cash Flow / Share (TTM)$4.06

EBITD / Share (Annual)$0.81

EPS Growth (3Y)-2.41%

Operating Margin (Annual)13.04%

LT Debt / Equity (Annual)0.00x

P/CF (TTM)17.73x

ROI (5Y Avg)14.08%

P/E Excl Extra (TTM)31.22x

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$0.41

P/TBV (Quarterly)3.82x

Payout Ratio (Annual)15.87%

P/B Ratio (Annual)2.76x

Dividend / Share (TTM)$0.08

Inventory Turnover (TTM)1.66x

Pretax Margin (TTM)12.16%

Book Value / Share (Annual)$4.77

Price vs S&P 500 (13W)-13.26%

Net Margin Growth (5Y)3.97%

Dividend Yield (TTM)0.66%

Beta0.19x

P/FCF (Annual)54.88x

Revenue / Share (TTM)$4.18

ROE (TTM)4.24%

52-Week Low$11.54

vGradeD

gGradeD

mGradeC

vgmGradeC

RDY Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

3.32

3.36

2.87

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80
TVTXTravere Therapeutics, Inc. Common Stock	F	B	A	$67.01

About Dr. Reddy's Laboratories Limited American Depositary Shares

Dr. Reddy's is one of the world's largest generic pharmaceutical manufacturers with diversified operations spanning generic drugs, injectables, and active pharmaceutical ingredients. The company generates approximately half its generics revenue from North America, with additional significant contributions from India (20%), Russia (10%), and other international markets; injectables represent 25% of North American sales. The company maintains top-five market positions in key Indian therapeutic areas including oncology and gastroenterology through its branded generics portfolio. Its API division manufactures 150+ active ingredients supplied across more than 75 countries.